AMICUS THERAPEUTICS INTERNATIONAL HOLDING LTD
Get an alert when AMICUS THERAPEUTICS INTERNATIONAL HOLDING LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-05-08 (in 1y)
Last made up 2026-04-24
Watchouts
None on the register
Accounts
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“As detailed above Corporate support letters have been issued by Amicus Therapeutics Inc. which itself has been signed off as a going concern, further detail on going concern is contained in section 2.3 of notes to the financial statements below.”
Group structure
- AMICUS THERAPEUTICS INTERNATIONAL HOLDING LTD · parent
- Amicus Therapeutics UK Limited 100%
- Amicus Therapeutics GmbH 100%
- Amicus Therapeutics BV 100%
- Amicus Therapeutics KK 100%
- Amicus Therapeutics SAS 100%
- Amicus Therapeutics S.r.l 100%
- Amicus Therapeutics SP 100%
- Amicus Therapeutics Canada Inc 100%
- Amicus Therapeutics PTY 100%
- Amicus Therapeutics ApS 100%
- Amicus Therapeutics Europe Limited 100%
- Amicus Therapeutics Switzerland GmbH 100%
Significant events
- “The Group is also expanding with new products, in 2023, the European Commission (EC) and UK's Medicines and Healthcare Products Regulatory Agency (MHRA) fully approved Pombiliti + Opfolda for the treatment of late-onset Pompe disease (LOPD).”
- “In October 2023, Amicus Therapeutics Inc. entered into a loan agreement with Blackstone for $400m in order to repay existing group debt and provide adequate working capital for the future. As part of this agreement Amicus Therapeutics International Holding Ltd provided a first lien security interest over cash held in its bank account and its trade debtor balances.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GREEN, Steven John | Director | 2020-06-01 | Apr 1977 | British |
| STOCKWELL, Caroline Amelia | Director | 2024-04-18 | Nov 1966 | British |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GHYOOT, Geoffrey Marc Caroline | Director | 2016-04-26 | 2017-03-10 |
| MOCHAN, Lori Elizabeth | Director | 2018-05-04 | 2020-02-21 |
| PROUT, Samantha Lynn | Director | 2018-05-04 | 2024-02-01 |
| QUIMI, Daphne Elke | Director | 2021-12-01 | 2024-01-29 |
| QUIMI, Daphne Elke | Director | 2016-04-26 | 2018-05-04 |
| SARKARIA, Jasvinder Singh | Director | 2017-03-21 | 2018-05-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Amicus Therapeutics Inc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-26 | Active |
Filing timeline
Last 20 of 51 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-12-19 RESOLUTIONS Resolution
- 2023-10-23 RESOLUTIONS Resolution
- 2023-10-23 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-05-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-04-07 | AA | accounts | Accounts with accounts type full | |
| 2024-07-08 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-06-11 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-05-18 | AA | accounts | Accounts with accounts type full | |
| 2024-05-07 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-04-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-02-14 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-30 | TM01 | officers | Termination director company with name termination date | |
| 2023-12-19 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2023-12-19 | RESOLUTIONS | resolution | Resolution | |
| 2023-12-19 | CAP-SS | insolvency | Legacy | |
| 2023-12-19 | SH20 | capital | Legacy | |
| 2023-10-23 | RESOLUTIONS | resolution | Resolution | |
| 2023-10-23 | MA | incorporation | Memorandum articles | |
| 2023-10-13 | AA | accounts | Accounts with accounts type full | |
| 2023-10-12 | SH01 | capital | Capital allotment shares | |
| 2023-10-12 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-10-09 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-05-04 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 1
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
Latest filed period vs the prior one